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Background: We recently identified a novel protein, Rearranged L-myc fusion (Rlf), that is required for DNA
hypomethylation and transcriptional activity at two specific regions of the genome known to be sensitive to
epigenetic gene silencing. To identify other loci affected by the absence of Rlf, we have now analysed 12 whole
genome bisulphite sequencing datasets across three different embryonic tissues/stages from mice wild-type or
null for Rlf.
Results: Here we show that the absence of Rlf results in an increase in DNA methylation at thousands of
elements involved in transcriptional regulation and many of the changes occur at enhancers and CpG island
shores. ChIP-seq for H3K4me1, a mark generally found at regulatory elements, revealed associated changes at
many of the regions that are differentially methylated in the Rlf mutants. RNA-seq showed that the numerous
effects of the absence of Rlf on the epigenome are associated with relatively subtle effects on the mRNA
population. In vitro studies suggest that Rlf’s zinc fingers have the capacity to bind DNA and that the protein
interacts with other known epigenetic modifiers.
Conclusion: This study provides the first evidence that the epigenetic modifier Rlf is involved in the maintenance of
DNA methylation at enhancers and CGI shores across the genome.
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We recently reported that Rearranged L-myc fusion (Rlf )
acts as an epigenetic modifier [1]. The gene emerged
from a sensitized N-ethyl-N-nitrosourea (ENU) muta-
genesis screen carried out to identify factors involved in
epigenetic regulation of transcription. The screen was
based on the identification of mice with altered expres-
sion of a multi-copy GFP transgene that is susceptible to
epigenetic gene silencing [2]. This is a dominant screen
and we call the mutant lines Modifiers of murine meta-
stable epiallele Dominant (MommeD) [2]. We found that* Correspondence: e.whitelaw@latrobe.edu.au
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unless otherwise stated.three of the lines, MommeD8, MommeD28 and
MommeD34, carry mutations in Rlf and have designated
the alleles RlfMommeD8, RlfMommeD28 and RlfMommeD34. Of
these, RlfMommeD28 and RlfMommeD34 are null alleles and
RlfMommeD8 is hypomorphic [1]. Mice heterozygous for
the mutant alleles displayed increased silencing of both
the reporter transgene and another epigenetically sensi-
tive allele, agouti viable yellow [1]. Mice heterozygous
for Rlf mutations are viable, with no overt abnormalities.
Mice homozygous for the null alleles die around birth.
Little is known about the function of Rlf, although the
predicted presence of 16 widely-spaced zinc fingers
suggests a role in transcription [3]. Bisulphite sequen-
cing at the reporter transgene revealed increased DNAThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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embryos, consistent with its reduced expression [1].
To discover whether or not Rlf has functions at other
loci, we have carried out whole genome bisulphite se-
quencing at three different stages of development and
provide evidence that Rlf has a role in the maintenance
of DNA hypomethylation at thousands of elements
across the genome. These regions overlap with those
previously found to be differentially methylated across
different tissue types, called tissue-specific DMRs
(tsDMRs) [4-8]. Tissue-specific DMRs overlap with
elements involved in transcriptional regulation, in par-
ticular enhancers.
Here we show that Rlf has a role in maintaining DNA
hypomethylation at enhancers across the genome. Increases
in DNA methylation that occur in the absence of Rlf, are
accompanied by reductions in H3K4me1 occupancy.
Results
Loss of Rlf results in an increase in DNA methylation at
short lowly methylated regions across the genome
To understand how Rlf affects DNA methylation at a
genome-wide level, we carried out genome-wide bisul-
phite sequencing on the livers of E14.5 embryos (Rlf+/+
and RlfMommeD28/MommeD28). We chose E14.5 liver because
the original screen was carried out using erythroid cells
and the liver is the major erythropoietic tissue at this stage
of development. Also, since E14.5 embryonic liver is one
of ENCODE’s chosen tissues, associations can be made
between sites of differential DNA methylation and histone
marks. Mice homozygous for the null allele appear grossly
phenotypically normal at this stage, reducing the risk
of possible changes to DNA methylation that are the
consequence of their demise at later developmental
stages. Bisulphite sequencing was carried out on E14.5
livers from two wild-type (Rlf+/+) and two homozygous
(Rlf MommeD28/MommeD28) littermates to an average
depth of 30-fold per sample. Approximately 85% of the
CpGs in the mouse genome were covered by >5 reads
and approximately 75% were covered by >20 reads
(Additional file 1: Figure S1). For each CpG, the percent-
age of converted and unconverted Cs across all reads was
calculated (%mCG). Sequencing of unmethylated lambda
DNA, spiked into each sample, confirmed complete con-
version (>99%). Regions differentially methylated between
the wild-type and homozygous samples were identified
using the following parameters: the region must con-
tain >10 CpGs and each CpG must be covered by >5
reads. A call was made if the difference between the %
mCG of the wild-type (average of two) and homozygous
(average of two) samples was greater than 15%. Use of these
parameters might bias the analysis to CG rich regions.
We found 1,329 differentially methylated regions
across the genome and call these Rlf-DMRs (Additionalfile 2: Table S1). Hierarchical clustering of the Rlf-DMRs
showed that the two biological replicates of each geno-
type clustered together, attesting to the reproducibility
of the technology (Additional file 3: Figure S2). A repre-
sentative screen shot is shown (Figure 1A). One of the
Rlf-DMRs was the multicopy reporter transgene, the
expression of which had been used to identify the
MommeD mutants in the original mutagenesis screen.
This is consistent with our previous findings following
bisulphite PCR of a small segment of this element [1].
The Rlf-DMR extended across the 5 kb transgene, in-
cluding the HS-40 enhancer region (Figure 1B).
In general, the Rlf-DMRs were short (~1 kb), occurred
at regions of the genome that are less methylated than
the surrounding DNA (Figure 1C) and overlapped
with regions that are conserved in placental mammals
(Figure 1D). These characteristics are consistent with
those reported for tissue-specific differentially methyl-
ated regions (tsDMRs) [5]. Comparison of the two
datasets showed that 59% of the E14.5 liver Rlf-DMRs
overlapped with a tsDMR (data not shown). The fail-
ure of some to overlap is likely to be a reflection of
lower coverage in the data used to identify tsDMRs
[5]. Most of the Rlf-DMRs, (n = 1,246; 94%) were more
methylated in the mutants, consistent with our previ-
ous findings at the transgene locus (Figure 1E) [1].
Rlf–DMRs overlap with elements involved in
transcriptional regulation, including those at exons
Of the 1,329 Rlf-DMRs identified in E14.5 liver, approxi-
mately half overlapped with RefSeq transcripts (n = 652)
and half were intergenic (n = 677) (Figure 2A). A rela-
tively small proportion of the Rlf-DMRs, 255 of the
1,329, lay within 2.5 kb of a transcriptional start site
(TSS) and we found little overlap, 200 of the 1,329, with
the 16,000 CpG islands annotated in the mouse genome
in the UCSC Genome Browser. Together these findings
suggest that a minority of Rlf-DMRs overlap with pro-
moters, consistent with findings for tsDMRs [5] and T-
DMRs [4].
Of those Rlf-DMRs that overlapped with RefSeq tran-
scripts, a large proportion, ~50%, were at exons (includ-
ing the 3’UTR) (Figure 2B). This is significantly more
than would be expected based on the proportion of
genic sequence that is exonic (~10% of RefSeq tran-
scripts). Recent analysis of enhancer-specific ChIP-seq
data has revealed that many exons act as enhancers, af-
fecting transcription of either the gene in which they
reside or a neighbouring gene [10]. Our results are con-
sistent with this finding.
Using the ENCODE E14.5 liver dataset, we found that
287 of the 1,329 E14.5 liver Rlf-DMRs were enriched for
H3K4me1 ChIP-seq reads (Figure 2C), confirming over-
lap with enhancers. Only 130 of the 1,329 Rlf-DMRs
Figure 1 DNA methylation is increased at ~ one thousand loci in the genomes of RlfMommeD28/MommeD28 mice. (A) A UCSC Genome Browser
snapshot showing a representative Rlf-DMR, within the gene Bai2, with increased methylation in RlfMommeD28/MommeD28 compared to Rlf+/+ mice. The
gene’s exons are indicated by blue boxes, introns by connecting lines and direction of transcription by the intronic arrows. (B) The mice carry a GFP
transgene used in the ENU mutagenesis screen that identified Rlf as an epigenetic modifier [1]. Bisulphite sequencing reads covering the transgene
show hypermethylation of DNA from RlfMommeD28/MommeD28 mice throughout its length. Transgene sequence features, and a region previously targeted
by bisulphite PCR [1], are indicated. (C) The average methylation of regions differentially methylated in RlfMommeD28/MommeD28 mice, compared to
wild-type, are plotted. Only Rlf-DMRs >2.5 kb from TSS were included (n = 1,074). (D) Average PhastCons scores for placental mammals at Rlf-DMRs.
(E) Scatterplot of average CpG methylation observed in RlfMommeD28/MommeD28 mutants compared to wild-types for 1,329 Rlf-DMRs identified in E14.5 liver.
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monly associated with promoters. Many of the Rlf-
DMRs with H3K4me1 peaks also had H3K27ac peaks,
consistent with active enhancers (Figure 2C). Again, this
is reminiscent of what has been reported for tsDMRs
[5]. When a Rlf-DMR was associated with an unmethy-
lated CpG island, the methylation change tends to occur
at the boundaries, the CpG island shores (Figure 2D and
E). It is important to emphasise that most of the E14.5
liver Rlf-DMRs, 973 of 1,329, were not enriched for any
of these histone marks and might represent “vestigial”
enhancers (see discussion below).
Some E14.5 Rlf-DMRs were found to overlap with
DNA elements that have been tested for enhancer activ-
ity in vivo (VISTA database, [9]). In total 18 overlapped,
of which 11 had been found to be positive for enhancer
function. For example, a VISTA-validated intergenic Rlf-
DMR that lies between Smad3 and Smad6 was shown to
drive expression in neural tube at E11.5 (Figure 2F). The
differential methylation of this Rlf-DMR was validated inE14.5 liver tissue from Rlf+/+ and RlfMommeD34/MommeD34,
using bisulphite PCR sequencing (Figure 2G).
Loss of Rlf results in a decrease in H3K4me1 at discrete
regions across the genome
To ask whether loss of Rlf also affects chromatin marks
at Rlf-DMRs, we performed ChIP-seq for H3K4me1.
Chromatin was extracted from two wild-type and two
RlfMommeD28/MommeD28 E14.5 fetal livers. For each sample,
28–40 million reads were sequenced. We saw a good
correlation between our wild-type datasets and those in
ENCODE (data not shown). To enable characterisation of
H3K4me1 occupancy at the GFP transgene, a subset of
1x107 reads were selected from each dataset and mapped
to a mouse genome containing the sequence of the GFP
transgene as a separate chromosome. The GFP transgene
showed reduced H3K4me1 read coverage in homozygous
mutants, consistent with the observed increase in DNA
methylation and decrease in expression (Figure 3A). Nu-
merous changes in H3K4me1 occupancy at Rlf-DMRs
Figure 2 Rlf-DMRs overlap with regulatory regions. (A) E14.5 liver Rlf-DMRs were investigated for overlap with RefSeq genes, proximity to TSS
and CpG islands. (B) E14.5 liver Rlf-DMRs overlapping RefSeq transcripts, were classified according to overlap with transcript features. The central
CpG dinucleotide of each Rlf-DMR was used to define the overlap. Rlf-DMRs that overlapped multiple features were assigned to a single feature
according to following ranking: TSS > single exon transcripts > 3′ exon/untranslated region (UTR) > internal exon > intron. The expected distribution was
defined as the union of each feature category genome-wide, subtracting overlapping features of higher rank (1,006 Mb). (C) Counts of E14.5 liver Rlf-DMRs
enriched for the histone marks H3K4me1, H3K4me3 and H3K27ac in E14.5 liver (obtained from ENCODE) (D) Heat plots showing DNA methylation and
H3K4me3 levels surrounding E14.5 liver Rlf-DMRs. (E) Plot showing position of E14.5 liver Rlf-DMRs relative to CpG Islands for Rlf-DMRs located within 5 kb
of a CpG island. The data has been plotted around the centre of the CpG island and sorted according to the methylation level of the CpG island. (F) An
example of region of DNA at a Rlf-DMR that has been shown to have enhancer properties in neural tube and forebrain of E11.5 embryos [9]. (G) Bisulphite
PCR validation of the E14.5 liver Rlf-DMR located between Smad3 and Smad6.
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H3K4me1 enrichment, the majority showed a decrease in
H3K4me1 in the mutants, consistent with that expected
from the DNA methylation change (Figure 3B).Whilst H3K4me1 marks active and poised enhancers,
H3K27ac marks active enhancers and promoters [11].
To assess whether loss of Rlf specifically affects active
enhancers, we divided Rlf-DMRs into two groups; those
Figure 3 Rlf homozygous mutants show altered H3K4me1 occupancy across the genome. (A) H3K4me1 occupancy at the GFP transgene
in chromatin extracted E14.5 fetal livers of two Rlf+/+ and two RlfMommeD28/MommeD28 mice. (B) Scatter plot showing H3K4me1 occupancy at E14.5
liver Rlf-DMRs (C) A box-whisker plot showing H3K4me1 abundance in Rlf+/+ and RlfMommeD28/MommeD28 mice at loci overlapping either putative
active or poised regulatory regions in the E14.5 liver (marked by H3K4me1 and H3K27ac or H3K4me1 only, respectively). In both cases RPKM values for
the homozygous replicates are significantly different from the wild-type replicates (Mann–Whitney U test: p < 1×10−8). (D) Scatter plot showing fold
change of peaks with >50% alteration in H3K4me1 occupancy. Red and blue dots represent peaks either within 2 kb of a Rlf-DMR or further from a
Rlf-DMR, respectively. (E) Screen shot showing a representative region with reduced H3K4me1 occupancy in RlfMommeD28/MommeD28 mutants samples
compared to Rlf+/+ mice. The position of three E14.5 liver Rlf-DMRs are represented by green boxes.
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H3K27ac and those with only the former (Figure 3C).
The box–whisker plots show that in both groups
H3K4me1 occupancy was significantly reduced in homo-
zygous mutants compared to wild-types (Figure 3C).
This finding suggests that at Rlf-DMRs, loss of Rlf
affected H3K4me1 occupancy at both active and poised
enhancers.
We were keen to see if H3K4me1 occupancy was
affected at other sites in the genome. H3K4me1 peakswere identified and after combining peaks from each
of the four datasets, a total of 38,689 were obtained
(Additional file 4: Table S2). Analyses of H3K4me1 oc-
cupancy at these peaks revealed numerous changes in
Rlf mutants compared to wild-types. Using a fold-
change cut-off of 50%, 686 sites were found with in-
creased occupancy and 856 with reduced occupancy.
The majority of altered sites showed modest fold
changes. Only a small subset of sites that showed
H3K4me1 changes had a Rlf-DMR within 2 kb (Figure 3D;
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creased, as expected. This means that many of the sites
with decreased H3K4me1 occupancy did not have a
Rlf-DMR within 2 kb. The width of peaks with altered
H3K4me1 were generally larger than the width of Rlf-
DMRs, consistent with data from others on the width of
H3K4me1 peaks at and around enhancers (Figure 1C &
Figure 3D) [5]. Figure 3E shows a representative screen
shot of one of the regions in which H3K4me1 occupancy
was found to be reduced in Rlf homozygous mutants.
Our results suggest that in at least some settings loss
of Rlf was sufficient to induce a histone change in the
absence of a DNA methylation change.
Rlf-DMRs exist across a range of tissues and
developmental stages
Data from the ENCODE E14.5 liver showed that the ma-
jority of the E14.5 liver Rlf-DMRs (973 of the 1,329) were
not enriched for H3K4me1, H3K27ac or H3K4me3, rais-
ing the possibility that many Rlf-DMRs might be active
enhancers in another tissue or at a different stage of devel-
opment. Indeed, others have noted differentially methyl-
ated regions of the adult genome that are not active
enhancers but are likely to have been at an earlier stage in
development, termed “vestigial” [5]. To test this idea, EN-
CODE’s H3K4me1 reads in E14.5 brain and heart were in-
terrogated and an additional 478 E14.5 liver Rlf-DMRs
were found to be enriched for H3K4me1 in one or other
of these tissues (Figure 4A). This suggests that many, if
not all, of the Rlf-DMRs without active histone marks in
E14.5 liver were active as enhancers in other tissues.
Western blot analysis showed that Rlf is expressed in
many adult, fetal and embryonic tissues (Figure 4B and
data not shown). Based on this finding, we repeated the
whole-genome bisulphite sequencing at both an earlier
stage (E10.5 whole embryo) and a later stage (E18.5
liver). We used E18.5 liver because it has a different cell
type make-up from E14.5 liver and the cell type ratios
are known. At E14.5, the liver is the major haematopoi-
etic organ, with 56% of cells being Ly76+ (erythroblasts)
and 23% being Krt8+ Acta2− epithelial cells (hepato-
blasts). By E18.5, erythroblasts represent only 7% of the
total cells and hepatoblasts become the dominant cell
type, making up 82% of the total cell population [13].
We collected two wild-type and two homozygous sam-
ples in each case and sequenced to 15 fold depth. In
order to make comparisons between these datasets and
our previous datasets (E14.5 liver), we carried out sub-
sampling to equalise the depth of reads across all three
(see Methods). Interrogation of a random selection of 1 kb
fragments across the genome confirmed that subsampling
had little effect on the weighted average of methylation in
these regions (Additional file 5: Figure S3). The global
CpG methylation level, shown as CpG methylation levelsaveraged across 10 kb windows, differed across the three
tissue types but in each case the overall level was un-
affected by lack of Rlf (Figure 4C).
A total of 1,199 Rlf-DMRs were identified from the
E14.5 liver dataset (Additional file 6: Table S3). The dis-
crepancy between this figure and the 1,329 previously
identified is due to the subsampling and slightly altered
parameters used (see Methods). Additionally, 2,206 were
called from the E10.5 whole embryo dataset and 1,514
from the E18.5 liver dataset (Additional file 6: Table S3),
resulting in a total of 4,919 Rlf-DMRs across all three
datasets.
After merging overlaps, 3,700 remained as unique co-
ordinates. Many were shared and, as expected, the ma-
jority were more methylated in the mutants. From the
heat-plot it is evident that the Rlf-DMRs showed surpris-
ingly similar patterns of methylation change in the two
liver datasets, despite quite different cell type popula-
tions (Figure 4D).
We then asked how many of these 3,700 were differen-
tially methylated in one or two but not all of the three
datasets. 986 were found to have a smaller than 5%
methylation difference in at least one tissue, suggesting
that they were not Rlf-DMRs in that tissue (Additional
file 7: Figure S4).
Because of the large change in cell type between the
E14.5 liver and E18.5 liver, we were interested to see
how many Rlf-DMRs were different across these two
datasets. We found only 200 Rlf-DMRs that were called
in one but not the other (Additional file 8: Figure S5).
In summary, Rlf-DMRs were identified in all tissues/
stages tested and a subset was unique to each dataset.
Gene ontology analysis of the genes closest to the
3,700 Rlf-DMRs failed to identify any specific class of
gene except for an enrichment for genes encoding tran-
scription factors (data not shown). Because Rlf-DMRs
were found at regulatory elements, we searched for
enriched consensus DNA binding motifs at Rlf-DMRs.
No motifs were found to be significantly enriched over
background (data not shown).
Rlf interacts with chromatin-associated proteins involved
in transcription and replication and binds DNA in vitro
Given that Rlf was found to be required for normal
DNA methylation status at regulatory elements through-
out the genome, we were interested to find protein part-
ners. Co-immunoprecipitation (co-IP) experiments were
performed. Human HEK293T cells expressing either a
Flag-tagged RLF cDNA (RLF-Flag) or an empty vector
control (EV) were generated via transient transfection.
Anti-Flag conjugated magnetic beads were used to co-IP
tagged RLF from nuclear lysates. Eluted proteins were
identified by mass spectrometry. Three biological repli-
cates were used in each case and the data were analysed
Figure 4 Rlf-DMRs occur across a range of tissues and developmental stages. (A) Overlap with the enhancer mark H3k4me1 in ENCODE
E14.5 liver, heart and brain tissues. ChIP-seq enrichment was defined as elements with ChIP-seq RPKM greater than two-fold enriched over input
RPKM for both replicates. (B) Representative Western blot showing Rlf protein expression in lysates prepared from fetal and adult wild-type mouse
tissues. γ-tubulin was used as a loading control. (C) Box plots of percent mCG calculated from non-overlapping 10 kb bins for each whole genome
bisulphite sequencing dataset used for this study. Additionally, the percent mCG distribution for adult liver (accession: GSM1051157); [5], obtained from
the Gene Expression Omnibus [12], is included. The edges of the box-plot represent the 25th and 75th percentiles, the central bars indicate medians
and whiskers indicate non-outlier extremes. (D) Hierarchical clustering showing methylation levels in E10.5 embryo, E14.5 liver and E18.5 liver for sites
identified as Rlf-DMRs in E14.5 liver. Each row represents a Rlf-DMR and each data point represents the weighted average of the percent mCG for the
Rlf-DMR in that sample.
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ered significant if they showed at least a 5-fold enrich-
ment in RLF-Flag samples compared to EV samples. A
complete list of binding partners is shown in Figure 5A
and the number of peptides detected in each biological
sample is shown in Additional file 9: Table S4. Many of
the identified proteins have established roles in tran-
scription and chromatin modification, or in replication
and DNA repair, as indicated (Figure 4A). A subset of
the binding partners was tested using Western blot ana-
lysis of independent samples (Figure 5B). All that were
tested in this way, validated.
To test whether Rlf has the capacity to bind DNA, we
performed electrophoretic mobility shift assays (EMSAs)
using two non-overlapping sub-fragments of Rlf, Rlf431–513
and Rlf1001–1362, that contain two and six zinc fingers, re-
spectively (Figure 5C & D). Recombinant GST-fusion Rlfprotein fragments were purified from E. coli and incu-
bated with Fluorescein amidite (FAM)-labelled oligo-
nucleotide probes, called pentaprobes, which have been
used previously to test DNA binding [14]. A protein
fragment containing the C-terminal zinc finger of Gata1,
which is known to bind DNA, was included as a positive
control. Incubation with either Rlf1001–1362 or Gata1CF re-
sulted in a shift in the migration pattern of both probes.
No shift was detected with Rlf431–513 fragment (Figure 5D).
The results suggest that Rlf binds DNA directly, but not
all zinc fingers in Rlf mediate DNA interactions.
Loss of Rlf affects mRNA levels of some genes in E14.5
fetal liver
To address whether the absence of Rlf influenced tran-
scription, we conducted RNA-seq on polyadenylated RNA
from E14.5 fetal liver of wild-type and Rlf homozygous
Figure 5 Rlf interacts with DNA and with proteins associated with transcription, chromatin modification and DNA replication and/or
repair. (A) Summary of RLF interacting proteins determined by co-IP and mass spectrometry of HEK293T cells expressing RLF-Flag or an EV
control (for details, see Additional file 9: Table S4). Proteins are grouped into categories and complexes based on previously reported functions.
Three independent biological replicates were analysed per condition. Proteins classified as interacting partners were significantly enriched in
RLF-Flag samples, p < 0.05, and are supported by at least five peptides. (B) Western blots showing co-IP of endogenous KDM1A, RCOR1, CBX5,
MRE11A, RAD50 and NBS1 with exogenous RLF-Flag in transiently transfected HEK239T cells. Input represents 1% of the nuclear extract used for
immunoprecipitation. Representative Westerns from at least three independent experiments are shown. (C) Schematic representation of mouse
Rlf showing putative zinc finger domains. GST-fusion proteins used in EMSA experiments, Rlf431–513 and Rlf1001–1362, are also presented. (D) EMSA
analysis testing the capability of GST-RLF fusions, Rlf431–513 and Rlf1001–1362, to bind to FAM labeled oligonucleotide probes, PP2 (lanes 4–9) or PP4
(lanes 13–18). Gata1CF, which is known to interact with DNA, was used as a positive control (lanes 1–3 and 10–12).
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were detected, using an adjusted p-value <0.05 (Figure 6A,
red circles and green, blue and purple triangles, and
Additional file 10: Table S5). A similar number of upand down-regulated genes were observed relative to
wild-type controls. We asked if these differentially
expressed genes were proximal to either a Rlf-DMR
(green triangle) or a site with reduced H3K4me1 occupancy
Figure 6 Loss of Rlf influences transcription in the fetal liver and is associated with alterations in epigenetic state. (A) Volcano plot
depicting the results of RNA-seq analysis of RNA from E14.5 livers of Rlf+/+and RlfMommeD28/MommeD28 mice. Three independent biological replicates
were analysed per genotype. Significantly differentially expressed genes are presented as red, blue, green or purple data points, p < 0.05. Genes
that have either a Rlf-DMR or a Rlf-dependent change in H3K4me1 occupancy within 50 kb of their TSS are highlighted by green and purple
triangles, respectively. Blue triangles highlight genes with a change in both DNA methylation and H3K4me1 occupancy. Black data points
represent genes whose expression was not significantly altered by loss of Rlf. (B) Table showing the number of genes significantly differentially
expressed in RlfMommD28/MommeD28 E14.5 livers relative to Rlf+/+ controls at various fold-change cut-offs (p < 0.05). ↑ and ↓ indicates increased or
reduced expression, respectively, in Rlf MommeD28/MommeD28 homozygotes. (C) Quantitative real-time RT-PCR analysis of putative Rlf-regulated genes
identified via RNA-seq. Analyses used RNA extracted from E14.5 fetal livers of wild-type mice and an independent null Rlf mutant mouse line,
MommeD34, see Introduction. Mean ± SEM is present for at least six individuals per genotype. Statistical significance was determined via a t-test
*p < 0.05, **p < 0.005.
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These were identified and were found to preferentially
partition to the genes with reduced expression in the mu-
tants, consistent with an association with transcription.
Most of those with a greater than 1.5-fold change showed
reduced expression in the mutants (Figure 6B).
Ingenuity pathway analysis of significantly differentially
expressed genes (p < 0.05) showed an over-representation
of genes involved in the following networks: Cardiovascu-
lar System Development and Function, Organismal Devel-
opment, Tissue Development (p score = 52); Cancer,
Cellular Development, Cellular Growth and Proliferation
(p score = 30); and Lipid Metabolism, Small Molecule Bio-
chemistry, Nucleic Acid Metabolism (p score = 19). Real-
time RT-PCR using RNA from an independent Rlf mutant
mouse line, RlfMommeD34/MommeD34, was used to validateRNA-seq findings for four up-regulated and four down-
regulated genes (Figure 6C). In several cases, heterozygos-
ity for the Rlf mutant allele also resulted in significant
changes in gene expression (Figure 6C), suggesting that
dosage of Rlf might be critical in some contexts.
Taken together with our earlier findings, this data sup-
ports a role for Rlf in transcription.
Discussion
Cytosine methylation has a fundamental role in differen-
tiation and development in mammals but the mechan-
ism is unclear. Three recent studies of differential
methylation in mice and humans found hundreds of
thousands of regions that were differentially methylated
across different tissues, called ts-DMRs [4,5,7]. Many of
these differentially methylated regions overlapped with
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marks associated with active enhancers (H3K4me1 and
H3K27ac). Here we report that the recently identified
epigenetic modifier, Rlf, is involved in the process of
establishing and/or maintaining low levels of DNA
methylation at a subset of these cis-regulatory elements.
The enhancers involved are not specific to one or a few
cell types nor can they be assigned to genes of one of a
few functional categories. Our studies, carried out in
only three different tissues/stages in development have
revealed 3,700 unique locations but studies in additional
cell types are likely to reveal many more.
One of the interesting observations made in the stud-
ies identifying ts-DMRs was that many lacked the
H3K4me1 and H3K27ac marks associated with active or
poised enhancers, even in the tissues in which the locus
was hypomethylated, raising the possibility that the re-
gions had been active early in development, had become
inactive but remained hypomethylated. The term “vestigial
enhancer” was used to describe this class [5]. Our results
show that Rlf is also involved in the maintenance of hypo-
methylation at such sites.
Independent studies have shown that most tissue-
specific differential methylation occurs at CpG island
shores [15] and others have speculated that the methyla-
tion of these sites will turn out to be transcription factor
dependent [16]. Our findings support this model, with
the absence of Rlf resulting in increased DNA methyla-
tion at CpG island shores.
Mice null for Rlf weigh noticeably less at late gestation
and die shortly after birth [1]. Here we report wide-
spread effects on DNA methylation that are observed as
early as mid-gestation (E10.5). RNA-seq on E14.5 embry-
onic livers reveals that a number of genes were affected by
the absence of Rlf, although these effects are relatively
subtle. The majority of these genes are down regulated in
homozygous Rlf mutants. Many of these changes are asso-
ciated with the expected chromatin modifications i.e.
increased DNA methylation and decreased H3K4me1.
Taken together this suggests a role for Rlf in transcrip-
tional activation. The relatively mild nature of the tran-
scriptional changes observed might indicate that in some
settings the loss of Rlf alone is not sufficient to alter tran-
scription. Further study is required to uncover the precise
mechanism through which Rlf influences gene expression.
Electrophoretic mobility shift assays indicate that Rlf
can interact with DNA directly and it has been proposed
that the binding of transcription factors, such as CTCF
and REST, at transcriptional regulatory regions is suffi-
cient for hypomethylation [6]. These binding events could
act simply by preventing the binding of other factors such
as DNA methyltransferases or by actively recruiting fac-
tors such as Tet enzymes. The co-immunoprecipitation
studies support the idea that Rlf acts in concert with otherproteins that have known roles in transcriptional regu-
lation. The histone demethylase, KDM1A, which co-
immunoprecipitated with RLF, is normally associated
with transcriptional silencing. However, it has also
been found in a complex with the androgen receptor
and in this context it acts as an activator by demethy-
lating H3K9me2 marks at transcriptional enhancers
[17]. This mechanism would be consistent with the
predominantly activating effect of Rlf on transcription.
Although ChIP-seq studies are likely to shed light on
these possible mechanisms in terms of genome occu-
pancy and co-occupancy, suitable antibodies for Rlf are
not currently available. In the absence of ChIP-seq data
for Rlf, we have used whole genome bisulphite sequen-
cing, ChIP-seq for H3K4me1 and RNA-seq as tools to
identify regions of the genome where the absence of Rlf
has an effect, linking it to enhancers and transcriptional
activation. We have also found that the global levels of
CpG methylation are not changed by lack of Rlf, making
indirect mechanisms e.g. via changes to DNA methyltrans-
ferase activity, an unlikely explanation for our findings.
Whereas proteins with closely spaced arrays of zinc
fingers (such as Krϋppel zinc finger proteins) are rela-
tively common in the genome and are well known as
DNA-binding factors, proteins with widely-spaced zinc
fingers, like Rlf, are less common and are poorly charac-
terised. The significance of the wide spacing is unknown
[18]. Interestingly, several other widely-spaced zinc finger
proteins have been identified in association with epigen-
etic programming. For example, Su(var)3-7 was identified
in the original Drosophila screen for modifiers of position
effect variegation [19], and Wiz, was identified in our
screen for modifiers of epigenetic reprogramming in mice
[1]. Only a small number of additional widely-spaced zinc
finger proteins have been described in the mouse, includ-
ing the Rlf paralog Zfp292 [20] and Peg3 [21], both of
which can bind DNA, and Zfp346 (Jaz) and Zmat3
(Wig-1), both of which can bind double-stranded RNA
[22,23]. Despite being derived from the same ancestral
gene, Rlf and Zfp292 have diverged considerably, in-
cluding at the putative zinc fingers. Further studies will
reveal how similar these proteins are in their functions.
Conclusion
Overall our data show that Rlf has a prominent role in
the modulation of epigenetic state at cis-acting regula-
tory regions across the genome. Future studies of this




MommeD28 and MommeD34 mouse lines were pro-
duced in an ENU mutagenesis screen for epigenetic
Harten et al. BMC Biology  (2015) 13:21 Page 11 of 15modifiers and have been described previously [1]. The
ENU screen was carried out in Line3 FVB/NJ mice car-
rying a multi-copy GFP transgene under the control of
the human alpha-globin promoter and the HS-40 enhan-
cer. All mice used in this study were homozygous for
the GFP transgene array. ENU mutant lines have been
maintained as inbred colonies by backcrossing to unmu-
tagenised Line3 mice for at least ten generations. All
procedures were carried out with approval from the Ani-
mal Ethics Committee of the QIMR Berghofer Medical
Research Institute.
DNA and RNA extraction
Embryonic tissues were obtained from natural timed-
matings of heterozygous individuals, with the presence
of a post-coital plug defined as E0.5. Pregnant dams were
euthanised via cervical dislocation at the required time
point. Whole embryos (E10.5) or fetal livers (E14.5 &
E18.5) were removed and homogenised in RLT Plus Buffer
(Qiagen, Doncaster, VIC, Australia) using a syringe and
needle. Genomic DNA and total RNA were prepared
using an AllPrep DNA/RNA Mini Kit according to manu-
facturers’ instructions (Qiagen, Doncaster, VIC, Australia).
Genotyping of DNA was performed by Sanger sequencing.
Primers: MommeD28 Geno F: TCT GCC AGT CTC
TGA AGA AAA GGC A, MommeD28 Geno R: CTG
TGG CTT TCA TTC TGG AAG GGA A; MommeD34
Geno F: GTTGCCCATTTTAGGGGAG, MommeD34
Geno R: TGGATTGCACCCTGGACTAC.
Whole Genome Bisulphite Sequencing
Whole Genome Bisulphite Sequencing was performed
by the Centro Nacional de Análisis Genomico (CNAG,
Barcelona, Spain). Genomic DNA samples were spiked
with λ DNA and sheared by sonication. Libraries were
prepared using the TruSeq Sample Prep Kit (Illumina,
San Diego, CA) and underwent two rounds of sodium
bisulphite conversion using the EpiTect Bisulphite Kit
(Qiagen, Doncaster, VIC, Australia). 100 bp paired end
sequencing was performed on the Illumina HiSeq 2000.
Sequencing reads were trimmed for poor quality at their
3′ ends using the program trim_seq [24] with the op-
tions -l 3 -m 3. Reads were mapped to mouse genome
(NCBI37/mm9) after first converting known FVB SNPs
to the FVB state using the tool FastaAlternate from the
GATK package [25]. The SNP positions were obtained
from Sanger (rsIDdbSNPv137) and coordinates con-
verted from the NCBI38/mm10 to NCBI37/mm9 using
the LiftOver tool from UCSC [26]. Only nucleotide
substitutions were used to maintain genome length.
The lambda genome sequence and the sequence for
the GFP transgene [27] were added to the genome se-
quence as separate chromosomes. Sequencing reads
were mapped to the new genome using the programBismark, version 0.7.12, [28] combined with Bowtie2,
version 2–2.1.0 [29], using the options -N 1 -D 30. The
resulting files were filtered for PCR duplicates using
the program deduplicate_bismark_alignment_output.pl
and CpG methylation values were then extracted using
the program bismark_methylation_extractor with the
options –ignore_r2 2 –counts –bedGraph –paired-end
–no_overlap –comprehensive –merge_non_CpG [28].
The CpG methylation calls (one for each strand) were
merged to a single methylation call for each CpG using
custom scripts.
For the full E14.5 liver datasets, differentially methylated
regions were identified using the R package bsseq [30].
The smoothing was carried out with the options ns = 20,
h = 250, maxGap = 100,000,000. Loci with coverage ≥8 in
at least one biological replicate for wild-type and
mutant were retained and Rlf-DMRs were identified
using t-statistic quantile cut-offs of 0.01 and 0.99, re-
quiring >10 CpGs per Rlf-DMR and a mean methy-
lation change >15%.
The 10.5 embryo dataset, the E18.5 liver dataset and
the sub-sampled E14.5 liver dataset (sub-sampled to
equal the mean library read-counts of the 10.5 embryo
and the E18.5 liver datasets) were mapped to the genome
and methylation values obtained, as described above. To
enable comparison between the tissues, methylation
values for CpGs covered by at least 6 CpGs in all samples
were extracted and Rlf-DMRs called across mutants and
wild-types for each tissue using bsseq, smoothing with the
options ns = 50, h = 500, maxGap = 10,000,000, requiring a
coverage of at least 6 in both replicates and a maximum
gap of 1,500 bp between CpGs in a Rlf-DMR. Rlf-DMRs
with ≥8 CpGs and mean methylation change >15% were
used for downstream analyses.
Methylation values used for hierarchical clustering
were the weighted averages of CpG methylation within
each genomic coordinate. Only coordinates containing
at least 8 CpGs with coverage of at least 6 reads across
all samples, were used.
Enrichment of histone marks
To calculate enrichment of histones at Rlf-DMRs the
ENCODE sequencing reads [31] for both biological rep-
licates, and for the input, for each tissue and histone
modification considered in this manuscript (E14.5 liver,
E14.5 heart and E14.5 brain), were obtained from the
UCSC Genome Browser [32]. Datasets with longer reads
were 3′ trimmed such that all datasets contained reads
of equal length. The reads were subsequently mapped to
the mouse reference genome (NCBI37/mm9) using the
program Bowtie2 with the options –trim5 6 –local -L
22 -N 1 retaining only uniquely mapped reads. Reads
likely to be PCR duplicates were identified and re-
moved using the program MarkDuplicates Picard [33].
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as described in [5], requiring >2-fold enrichment over
input for both replicates.
Gene ontology analyses, DNA sequence motif search and
conservation scores
Gene ontology analyses of genes proximal to Rlf-DMRs
were carried out using the GREAT tool [34]. The Homer
tool, version 4.6 [35], was used to investigate for enrich-
ment of known and novel transcription factor binding
motifs at Rlf-DMRs using the options -size given –cpg,
and otherwise default parameters. PhastCons conserva-
tion scores [36] for placental mammals, obtained from
the UCSC Genome Browser [37], were used to get aver-
age conservation scores for Rlf-DMRs.
Bisulphite sequencing at Smad 3–6 locus
Bisulphite conversion of genomic DNA was carried out
using the EpiTect Bisulphite Kit (Qiagen, Doncaster, VIC,
Australia). Nested PCRs were performed to interrogate
methylation at the Smad3-6 intergenic region with the fol-
lowing primers: Smad3-6 bis F1: AAGTGGAATTTTTT
AGTGGTAGATG; Smad3-6 bis R1: AACTACTTTAA
TAAAAAATAACATAACC, Smad3-6 bis F2: TTGGTAT
GTGTTGTTTTTAGTTTTG and Smad3-6 bis R2: ACA
ATTTAACTATTCATTATATCTCTAACA. Cycling con-
ditions were as follows: Primary PCR, 94°C for 2 minutes
for 1 cycle; 94°C for 30 secs, 53°C for 30 secs, 72°C for 45
secs for 35 cycles and 72°C for 6 mins for 1 cycle. The
secondary PCR was performed using an annealing
temperature of 51°C. The PCR product was ligated into
pGEM T Easy (Promega, Annandale, Australia) and
transformed. DNA from individual colonies was se-
quenced using Sanger sequencing. The bisulphite con-
version rate was ≥98% and sequences were analysed
using BiQ Analyser software [38].
H3K4me1 ChIP-seq
H3K4me1 ChIP-seq library preparation, sequencing and
initial bioinformatical analyses were carried out by Acti-
veMotif. Briefly, the prepared libraries were sequenced
on the Illumina NextSeq 500 platform using a read
length of 75 nt. Each resulting dataset was sub-sampled
to the read-count of the library with the smallest num-
ber of reads and aligned to the mouse genome (mm9)
using BWA [39] with default parameters, allowing a
maximum of two mismatches. Only uniquely mapping
reads were retained and reads identified as PCR dupli-
cates were discarded.
Mapped reads were then extended from their 3′ ends
to a length of 200 bp to account for the length of the
ChIP fragments used to prepare the libraries. The density
of fragments along the genome was obtained by dividingthe genome into 32-nt bins and the number of fragments
overlapping each bin was determined.
Regions enriched for H3K4me1 (i.e. peaks) were deter-
mined using the program MACS [40] using default pa-
rameters, and the resulting peaks from the four datasets
merged into a final set (union of peaks), which was then
used for the presented analyses.
The density of H3K4me1 reads across the GFP trans-
gene was determined by mapping 10,000,000 reads from
each library to a mouse genome (mm9) with the sequence
of the transgene added as an additional chromosome. The
reads were mapped using the program Bowtie2 [29] using
default parameters and retaining those reads with a mini-
mum mapping quality of 40.
co-IP/Mass Spec
HEK293T cells (ECACC, Salisbury, UK) were cultured in
Dulbecco’s Modified Eagle Medium (DMEM) with 10%
fetal bovine serum (FBS) (Life Technologies, Mulgrave,
VIC, Australia). Cells were transfected with a pCMV6-
Entry vector containing Myc-DDK-tagged-Human rear-
ranged L-myc fusion, RLF-Flag or vector alone, EV
(Rockville, MD, USA) using Lipofectamine 2000 (Life
Technologies, Mulgrave, VIC, Australia). After 48 hrs,
the cells were lysed with a hypotonic lysis buffer, nuclei
were isolated and resuspended in digestion buffer with
PMSF and protease inhibitors (Active Motif, Carlsbad,
CA, USA). For each replicate, 4 mg of nuclear lysate was
immunoprecipitated using anti-FLAG M2 magnetic
beads (Sigma-Aldrich, St. Louis, MO, USA). IP reactions
were carried out in High stringency IP buffer supple-
mented with protease inhibitor cocktail, for 1 hr at 4°C.
Samples were eluted with 8 M Urea. Digestion and IP
buffers were from the Nuclear Complex Co-IP kit (Active
Motif, Carlsbad, CA, USA). Eluted proteins were analysed
via mass spectrometry at the La Trobe University Mass
Spectrometry Facility. Samples were digested with 1 μg of
trypsin overnight at 37°C and peptide fragments analysed
via tandem mass spectrometry on an Orbitrap Elite mass
spectrometer (Thermo Scientific). Three biological repli-
cates were analysed per condition, with three replicate in-
jections performed for each. MS/MS spectra were queried
using Thermo Scientific Proteome Discoverer software v.
1.4 with Mascot (v. 2.4.0 Matrix Science) search engine.
Result files were imported into Scaffold (Proteome Soft-
ware Inc.) for visualisation and validation. Putative inter-
acting proteins were considered significant if they showed
at least a five-fold enrichment in RLF-Flag samples
compared to EV, with a p-value of <0.05, with at least
five peptides detected.
Western Blotting
Protein lysates from whole tissues were prepared by
homogenising in ten volumes of urea lysis buffer, as
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assay (Thermo Scientific, VIC, Australia), separated on
polyacrylamide gels (Bio-Rad, Gladesville, NSW, Australia)
and immunoblotted. Clarity Western ECL substrate
was used for visualisation (Bio-Rad, Gladesville, NSW,
Australia). Antibodies used were as follows: anti-RLF,
Ab115011 and anti-RCOR1, Ab32631 (Abcam, Cambridge,
UK); anti-LSD1, 2139 and anti-HP1α, 2616 (Cell Signaling,
Danvers, MA, USA); anti-Flag M2, F3165 and anti-
γ-tubulin, T5192 (Sigma-Aldrich, St. Louis, MO,
USA); anti-MRE11 (12D7) GTX70212, anti-NBS1 (1C3)
GTX70222 and anti-RAD50 (13B3) GTX70228 (GeneTex,
Irvine, CA).
Protein production and purification
Rlf sub-fragments were amplified from mouse cDNA
using the following primers, Rlf431 F: GCGGATCCG
GTTCCTCTGAGAGATACCAGAG, Rlf513 R: GCGA
ATTCCTATTAAGCGCTTTTCAATAGTAATTTCTT,
Rlf1001 F: GCGGATCCAGTCAGTACCTTGCACAGT
TGGC, Rlf1362 R: GCGAATTCCTATTA GCTGCTGA
ACAGGTTGTCATAATA and cloned into pGEX-6P,
for expression with an N-terminal GST tag, using
BamHI and EcoRI restriction sites. GST-Rlf protein
sub-fragments were overexpressed in Escherichia coli
Rosetta II cells with induction by IPTG. Cells were
lysed by sonication in lysis buffer (50 mM MES,
pH 6.5, 1 M NaCl, 1.4 mM β-mercaptoethanol, 1 mM
PMSF), incubated with 1 mg/mL DNase for 30 mins at
4°C, and further sonicated. The soluble fraction was
loaded onto glutathione-sepharose resin and washed
(50 mM MES, pH 6.5, 1 M NaCl, 10% (v/v) glycerol,
1.4 mM β-mercaptoethanol, 1 mM PMSF). GST-Rlf re-
combinant protein sub-fragments were eluted (50 mM
MES, pH 6.5, 150 mM NaCl, 50 mM reduced glutathi-
one, 1.4 mM β-mercaptoethanol, 1 mM PMSF) and
further purified by size exclusion chromatography on a
HiLoadTM Superdex 75 column (GE Healthcare Life
Sciences, Little Chalfont, United Kingdom).
EMSAs
EMSAs were performed using FAM labeled pentaprobe
oligonucleotides (Integrated DNA Technologies, Coralville,






CCTAATCCCACC. Reactions were performed in MSB
buffer (10 mM HEPES, pH 7.9, 30 mM NaCl, 1 mM
MgCl2, 20 μM EDTA) containing 10 mM DTT, 10 μM
ZnSO4, 67 μg/mL acetylated bovine serum albumin and
4% Ficoll. All reactions contained 5 nM oligonucleotideand either 0.5 μM, 5 μM or no protein. Samples were in-
cubated on ice for 30 min, separated on non-denaturing
polyacrylamide TBE gels and visualised using a Typhoon
FLA 9500 scanner (GE Healthcare Life Sciences, Little
Chalfont, United Kingdom).RNA-seq
mRNA-seq library preparation (Illumina TruSeq RNA
Sample Preparation kit; Illumina, San Diego, CA)
and Illumina HiSeq 2000 Sequencing with 50 bp
single-end reads was performed by the Australian
Genome Research Facility (AGRF, Melbourne, VIC,
Australia). Reads were aligned to the mouse genome
(NCBI37/mm9) using Tophat [41] with the parame-
ters -I 100000 –no-coverage-search –read-mismatches
2 –library-type fr-unstranded. Read counts for mRNA
transcripts were extracted from the mapped reads using
htseq-count [42] with the options -s no -m intersection-
strict and using gene annotations from Ensembl
([43], release 67). Differential gene expression was
assessed using the R-package DESeq, using default
parameters [44].Quantitative real-time RT-PCR
RNA was reverse transcribed using iScript Reverse
Transcription Supermix (Bio-Rad, Gladesville, NSW,
Australia). Quantitative real-time reverse transcription
(RT)-PCR analysis was performed on a Corbett Research
Rotor-Gene (Qiagen, Doncaster, VIC, Australia) using
Platinum SYBR Green qPCR Supermix-UDG (Life
Technologies, Mulgrave, VIC, Australia). Expression of
β-actin was used for normalisation. Statistical analysis
was performed using Student’s t test. Primer sequences
used are as follows: Aldh1a7 F: GCAGGGAAAAGCA
ATCTGAA, R: TCTGACCCTGGTGGAAGAAC; Vldlr
F: TCGGGCTTTGTTTACTGGTC, R: AGTAGAGG
CGGCTTTTGACA; Mgam F: TTGTTCTGCTGCTT
GTCCTG R: ACTGGGCAATTGGGAGAGTT; Myo5c
F: GGCTGAAATCGCAAAGGACT R: CTCATGGAG
GTAGCTGAGGG; Hpd: F: AGGTAGTCAGCCACG
TCATC, R: CAATGTGGTCGCAGTCCAGC; Prss50: F:
GGTTCATTCCAGCAACCTCC, R: GAAGCGATAA
GGATGCCAGC; Atp2b2 F: CCTCAAAACCTCGCCT
GTTG, R: GTGGGTGGTAGAAGGACAGT; Upb1 F: AG
GAATCTCGATCTGCCCAG, R: ATTGACTCCACACAT
TGCGG.Availability of supporting data
All methylome and RNA-seq datasets used in this study
have been submitted to the NCBI Gene Omnibus (GEO;
http://www.ncbi.nlm.nih.gov/geo/) under accession number
GSE58108.
Harten et al. BMC Biology  (2015) 13:21 Page 14 of 15Additional files
Additional file 1: Figure S1. Read coverage at CpG dinucleotides
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Additional file 5: Figure S3. Hierarchical clustering of %mCG for
random 1 kb regions from the bisulphite converted genomes prepared
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and E18.5 liver Rlf-DMRs identified using genome-wide bisulphite sequencing
of DNA from Rlf+/+ and RlfMommeD28/MommeD28 whole embryos or fetal liver.
Additional file 7: Figure S4. Hierarchical clustering of Rlf-DMRs with
normal methylation in at least one tissue.
Additional file 8: Figure S5. Hierarchical clustering of Rlf-DMRs
detected for only one liver timepoint.
Additional file 9: Table S4. Rlf interacting proteins identified via co-IP
of HEK293T nuclear lysates, expressing RLF-Flag or an empty vector, with
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peptides for each protein identified using Mass Spec.
Additional file 10: Table S5. Differential expression analysis comparing
RNA-seq datasets from Rlf+/+ mice to RlfMommeD28/MommeD28 mice.
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